These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 7768342)

  • 1. Cognitive function and academic performance in children with neurofibromatosis type 1.
    North K; Joy P; Yuille D; Cocks N; Hutchins P
    Dev Med Child Neurol; 1995 May; 37(5):427-36. PubMed ID: 7768342
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The nature and frequency of cognitive deficits in children with neurofibromatosis type 1.
    Hyman SL; Shores A; North KN
    Neurology; 2005 Oct; 65(7):1037-44. PubMed ID: 16217056
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Learning disabilities in children with neurofibromatosis type 1: subtypes, cognitive profile, and attention-deficit-hyperactivity disorder.
    Hyman SL; Arthur Shores E; North KN
    Dev Med Child Neurol; 2006 Dec; 48(12):973-7. PubMed ID: 17109785
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Behavioural, academic and neuropsychological profile of normally gifted Neurofibromatosis type 1 children.
    Descheemaeker MJ; Ghesquière P; Symons H; Fryns JP; Legius E
    J Intellect Disabil Res; 2005 Jan; 49(Pt 1):33-46. PubMed ID: 15634310
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The adverse influence of attention-deficit disorder with or without hyperactivity on cognition in neurofibromatosis type 1.
    Lidzba K; Granström S; Lindenau J; Mautner VF
    Dev Med Child Neurol; 2012 Oct; 54(10):892-7. PubMed ID: 22881119
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Motor impairment in children with Neurofibromatosis type 1: Effect of the comorbidity with language disorders.
    Iannuzzi S; Albaret JM; Chignac C; Faure-Marie N; Barry I; Karsenty C; Chaix Y
    Brain Dev; 2016 Feb; 38(2):181-7. PubMed ID: 26321374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of ADHD on the cognitive and academic functioning of children with NF1.
    Pride NA; Payne JM; North KN
    Dev Neuropsychol; 2012; 37(7):590-600. PubMed ID: 23066937
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cognitive profile and disorders affecting higher brain functions in paediatric patients with neurofibromatosis type 1.
    Vaucheret Paz E; López Ballent A; Puga C; García Basalo MJ; Baliarda F; Ekonen C; Ilari R; Agosta G
    Neurologia (Engl Ed); 2019; 34(6):353-359. PubMed ID: 28431841
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The handwriting performance of children with NF1.
    Gilboa Y; Josman N; Fattal-Valevski A; Toledano-Alhadef H; Rosenblum S
    Res Dev Disabil; 2010; 31(4):929-35. PubMed ID: 20392595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comorbidity and WISC-III profiles of Greek children with attention deficit hyperactivity disorder, learning disabilities, and language disorders.
    Filippatou DN; Livaniou EA
    Psychol Rep; 2005 Oct; 97(2):485-504. PubMed ID: 16342577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cognitive and neuropsychological outcomes: more than IQ scores.
    Aylward GP
    Ment Retard Dev Disabil Res Rev; 2002; 8(4):234-40. PubMed ID: 12454899
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Auditory temporal processing deficits and language disorders in patients with neurofibromatosis type 1.
    Batista PB; Lemos SM; Rodrigues LO; de Rezende NA
    J Commun Disord; 2014; 48():18-26. PubMed ID: 24447521
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An examination of lexical and sublexical reading skills in children with neurofibromatosis type 1.
    Watt SE; Shores A; North KN
    Child Neuropsychol; 2008 Sep; 14(5):401-18. PubMed ID: 17963094
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential influences on mathematical difficulties in children and adolescents with neurofibromatosis, type 1.
    Moore BD
    Dev Disabil Res Rev; 2009; 15(1):45-51. PubMed ID: 19213018
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cognitive deficits in neurofibromatosis 1.
    North K; Hyman S; Barton B
    J Child Neurol; 2002 Aug; 17(8):605-12; discussion 627-9, 646-51. PubMed ID: 12403559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurocognitive functioning in children with type-1 diabetes with and without episodes of severe hypoglycaemia.
    Hannonen R; Tupola S; Ahonen T; Riikonen R
    Dev Med Child Neurol; 2003 Apr; 45(4):262-8. PubMed ID: 12647928
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Natural history of cognitive deficits and their relationship to MRI T2-hyperintensities in NF1.
    Hyman SL; Gill DS; Shores EA; Steinberg A; Joy P; Gibikote SV; North KN
    Neurology; 2003 Apr; 60(7):1139-45. PubMed ID: 12682321
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Neuropsychological performance in neurofibromatosis type 1].
    Hernández Del Castillo L; Martínez Bermejo A; Portellano Pérez JA; Tirado Requero P; Garriz Luis A; Velázquez Fragua R
    An Pediatr (Barc); 2017 Aug; 87(2):73-77. PubMed ID: 27639957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurofibromatosis type 1: motor and cognitive function and T2-weighted MRI hyperintensities.
    Feldmann R; Denecke J; Grenzebach M; Schuierer G; Weglage J
    Neurology; 2003 Dec; 61(12):1725-8. PubMed ID: 14694037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuropsychological profile in adults with neurofibromatosis type 1 compared to a control group.
    Descheemaeker MJ; Plasschaert E; Frijns JP; Legius E
    J Intellect Disabil Res; 2013 Sep; 57(9):874-86. PubMed ID: 23095048
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.